How Relay Therapeutics, Inc. stacks up

RLAY · against 272 other Healthcare companies of similar size

Overall

48/ 100

Below the middle of the pack.

Ranked #176 of 273 · scores higher than 35% of peers

Bars: peers in each 10-point band of the overall score

40 peers with an overall score of 40–49, including RLAY · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#211 of 277Score 8 / 100 · beats 3%Growth#30 of 250Score 90 / 100 · beats 87%Profitability#266 of 273Score 4 / 100 · beats 2%Risk#21 of 271Lower relative risk · safety 92 · beats 93%

Ranking by overall score

Top 5 and the companies ranked around RLAY

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	BB Biotech AGBBZA.DE · Europe	3.1B EUR (≈$3.4B)	100		100	100	0 / 2
2	Lakefront Biotherapeutics NVLKFT · US-listed	2.1B USD	96	96	99	93	0 / 2
2	Zealand Pharma A/SZEAL.CO · Europe	15.6B DKK (≈$2.3B)	96	96	99	96	0 / 2
4	RemeGen Co., Ltd.9995.HK · Hong Kong	37.3B HKD (≈$4.8B)	90	99	98	84	0 / 2
5	InnoCare Pharma Limited9969.HK · Hong Kong	19.7B HKD (≈$2.5B)	84	84	98	87	0 / 2
⋯
171	Convatec Group PLCCTEC.L · United Kingdom	4.7B GBP (≈$6.1B)	49	62	43	74	2 / 2
171	DiaSorin S.p.A.DIA.MI · Europe	4.0B EUR (≈$4.4B)	49	68	23	76	2 / 2
176	Aspen Pharmacare Holdings LimitedAPN.JO · Other markets	70.9B ZAR (≈$3.9B)	48		31	51	1 / 2
176	Palvella Therapeutics, Inc.PVLA · US-listed	2.2B USD	48	33	—	11	0 / 2
176	Relay Therapeutics, Inc.RLAY · US-listed	3.8B USD	48	8	90	4	0 / 2
176	Tarsus Pharmaceuticals, Inc.TARS · US-listed	3.4B USD	48	8	96	28	1 / 2
180	AbCellera Biologics Inc.ABCL · US-listed	3.9B USD	47	8	84	10	0 / 2
180	Carl Zeiss Meditec AGAFX.DE · Europe	3.1B EUR (≈$3.4B)	47	64	39	58	2 / 2
180	Aster DM Quality Care LimitedASTERDM.NS · India	593.2B INR (≈$7.1B)	47	41	38	63	/ 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…